| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2022 | SMTI Sanara Medtech Inc. | Fleming Zachary B.50 | Chief Executive Officer | Sell | 1,680 | $22.36 | $37,564.25 | -1.5% | +34.8% | +64.9% | |
| Jul 5, 2022 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,545 | $212.33 | $328,049.85 | -1.4% | +3.8% | +0.4% | |
| Jul 5, 2022 | Hrusovsky E Kevin86 | Executive Chairman | Sell | 960 | $16.57 | $15,906.14 | -0.1% | -41.8% | +19.3% | ||
| Jul 5, 2022 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 13,504 | $35.06 | $473,450.24 | -22.7% | +20.1% | +132.7% | |
| Jul 5, 2022 | TMDX Transmedics Group, Inc. | Tobin James R60 | Director | Sell | 48,515 | $35.00 | $1,698,025.00 | -13.8% | +20.1% | +132.7% | |
| Jul 5, 2022 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.63 | EVP, Strategy Corp Dev Inv Rel | Sell | 1,428 | $108.93 | $155,552.88 | -1.8% | +9.2% | -12.3% | |
| Jul 5, 2022 | HYPR Hyperfine, Inc. | Siddiqui Khan54 | CMO And Chief Strategy Officer | Sell | 4,846 | $2.02 | $9,788.92 | -5.3% | -51.9% | +11.4% | |
| Jul 5, 2022 | TMCI Treace Medical Concepts, Inc. | Owens Daniel E.52 | Chief Hr Officer | Sell | 1,000 | $15.00 | $15,000.00 | -8.5% | +51.4% | +60.2% | |
| Jul 5, 2022 | EW Edwards Lifesciences Corp | Wood Larry L67 | Cvp, Tavr | Sell | 7,242 | $95.90 | $694,486.07 | -3.5% | -12.8% | -7.2% | |
| Jul 5, 2022 | HYPR Hyperfine, Inc. | Paykel Neela | Gen Counsel &Corp Secretary | Sell | 10,542 | $2.02 | $21,294.84 | -8.3% | -51.9% | +11.4% | |
| Jul 5, 2022 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 2,725 | $1.63 | $4,441.75 | -4.7% | +0.6% | +99.4% | |
| Jul 5, 2022 | HAE Haemonetics Corp | Miller Laurie A. | SVP, Human Resources | Sell | 42 | $66.18 | $2,779.56 | -0.3% | +14.1% | +26.2% | |
| Jul 5, 2022 | IRTC Irhythm Holdings, Inc. | Devine Douglas57 | Chief Operating Officer &CFO | Sell | 1,239 | $108.90 | $134,925.18 | -1.5% | +9.2% | -12.3% | |
| Jul 5, 2022 | Toloue Masoud57 | President &CEO | Sell | 432 | $16.57 | $7,157.76 | -0.5% | -41.8% | +19.3% | ||
| Jul 5, 2022 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 10,000 | $35.00 | $350,000.00 | -63.6% | +20.1% | +132.7% | |
| Jul 5, 2022 | PEN Penumbra Inc | Wilder Thomas57 | Director | Sell | 248 | $123.64 | $30,662.72 | -34.9% | +54.6% | +166.6% | |
| Jul 5, 2022 | Fry John J83 | General Counsel &Secretary | Sell | 387 | $16.57 | $6,412.16 | -1.0% | -41.8% | +19.3% | ||
| Jul 5, 2022 | ZBH Zimmer Biomet Holdings, Inc. | Van Zuilen Wilfred | Pres, Europe, M. East &Africa | Sell | 531 | $105.22 | $55,870.23 | -19.2% | +0.6% | +33.5% | |
| Jul 5, 2022 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | See Footnote 2 | Buy | 15,000 | $7.29 | $109,300.00 | +0.1% | +12.3% | +32.7% | |
| Jul 1, 2022 | MXCT Maxcyte, Inc. | Casdin Partners Master Fund, L.P.53 | 10% Owner | Sell | 3,235,548 | $4.30 | $13,912,856.40 | -23.2% | +34.5% | -1.7% | |
| Jul 1, 2022 | PETV Petvivo Holdings, Inc. | Lai John | CEO | Buy | 10,000 | $1.77 | $17,741.90 | +0.3% | - | - | |
| Jul 1, 2022 | PEN Penumbra Inc | Sarna Surbhi67 | Director | Sell | 27 | $124.39 | $3,358.53 | -1.3% | +52.6% | +173.7% | |
| Jul 1, 2022 | PODD Insulet Corp | Petrovic Shacey56 | Director | Sell | 15,000 | $222.90 | $3,343,500.00 | -52.3% | +2.1% | +27.3% | |
| Jul 1, 2022 | TELA Tela Bio, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 200 | $7.00 | $1,400.00 | +0.2% | +12.9% | +37.6% | |
| Jun 30, 2022 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 175,000 | $6.45 | $1,128,295.00 | +30.8% | +18.5% | -36.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.